Development of Bioinformatics Software for Drug Discovery and Design
American Journal of Bioinformatics · 31.08.2025 · 6 (4) · 1-6
DOI: 10.71465/ajb.3382 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Bioinformatics, online erschienen am 31.08.2025. Verfasst von Dr. David Thompson. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Bioinformatics software has become an essential tool in drug discovery and design, enabling researchers to analyze and predict molecular interactions, optimize drug candidates, and reduce the time and cost of drug development. The integration of bioinformatics techniques such as molecular docking, virtual screening, and quantitative structure-activity relationship (QSAR) modeling has revolutionized the process of drug design. This article explores the development of bioinformatics software tools used in drug discovery, focusing on their applications in target identification, drug screening, and lead optimization. We also discuss the challenges faced in developing these tools and the future directions in bioinformatics-driven drug design.
Zitieren
APA
Thompson, D. D. (2025). Development of Bioinformatics Software for Drug Discovery and Design. American Journal of Bioinformatics, 6(4), 1-6. https://doi.org/10.71465/ajb.3382
Vancouver
Thompson DD. Development of Bioinformatics Software for Drug Discovery and Design. American Journal of Bioinformatics. 2025;6(4):1-6. doi:10.71465/ajb.3382
BibTeX
@article{Thompson2025,
author = {Thompson, Dr. David},
title = {Development of Bioinformatics Software for Drug Discovery and Design},
journal = {American Journal of Bioinformatics},
year = {2025},
volume = {6},
number = {4},
pages = {1--6},
doi = {10.71465/ajb.3382}
}
EUVIMED